Personalis Inc diskutieren
Personalis Inc
WKN: A2PLTK / Symbol: PSNL / Name: Personalis / Aktie / Biotechnologie & medizinische Forschung / ? /
13,45 €
-1,80 %
Personalis, Inc. (NASDAQ: PSNL) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $8.00 price target on the stock.
Ratings data for PSNL provided by MarketBeat
Personalis, Inc. (NASDAQ: PSNL) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $7.00 price target on the stock.
Ratings data for PSNL provided by MarketBeat
Personalis, Inc. (NASDAQ: PSNL) had its price target raised by analysts at HC Wainwright from $8.00 to $9.00. They now have a "buy" rating on the stock.
Ratings data for PSNL provided by MarketBeat
Personalis, Inc. (NASDAQ: PSNL) is now covered by analysts at Guggenheim. They set a "buy" rating and a $6.00 price target on the stock.
Ratings data for PSNL provided by MarketBeat
Personalis, Inc. (NASDAQ: PSNL) had its price target lowered by analysts at HC Wainwright from $9.00 to $8.50. They now have a "buy" rating on the stock.
Ratings data for PSNL provided by MarketBeat
Personalis (NASDAQ:PSNL) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $8.50 price target on the stock.
Ratings data for PSNL provided by MarketBeat
Personalis (NASDAQ:PSNL) had its price target raised by analysts at BTIG Research from $6.00 to $11.00. They now have a "buy" rating on the stock.
Ratings data for PSNL provided by MarketBeat
Personalis (NASDAQ:PSNL) had its "buy" rating reaffirmed by analysts at Lake Street Capital.
Ratings data for PSNL provided by MarketBeat
Personalis (NASDAQ:PSNL) had its price target raised by analysts at HC Wainwright from $8.50 to $10.00. They now have a "buy" rating on the stock.
Ratings data for PSNL provided by MarketBeat
Personalis (NASDAQ:PSNL) had its price target raised by analysts at BTIG Research from $11.00 to $12.00. They now have a "buy" rating on the stock.
Ratings data for PSNL provided by MarketBeat
Personalis (NASDAQ:PSNL) had its price target raised by analysts at Guggenheim from $6.00 to $12.00. They now have a "buy" rating on the stock.
Ratings data for PSNL provided by MarketBeat
Personalis (NASDAQ:PSNL) had its "buy" rating reaffirmed by analysts at Guggenheim.
Ratings data for PSNL provided by MarketBeat
Personalis (PSNL) had its price target lowered by BTIG Research from $13.00 to $11.00. They now have a "buy" rating on the stock.
Ratings data for PSNL provided by MarketBeat
Personalis (PSNL) had its "buy" rating reaffirmed by TD Cowen.
Ratings data for PSNL provided by MarketBeat
Personalis (PSNL) had its price target raised by Needham & Company LLC from $12.00 to $17.00. They now have a "buy" rating on the stock.
Ratings data for PSNL provided by MarketBeat
Neueste Beiträge
Raymond_James in Karo Pharma AB diskutieren